We are pleased to announce that clinical research on GyroStim for Concussion/mTBI is underway!
Study purpose.
Clinical research is currently underway to document the efficacy of GyroStim as the first medical device ever to be cleared as a Breakthrough Medical Device for the treatment of concussion/mTBI.
This is a second, more specific indication for use in addition to the existing FDA designation for use in treating balance disorders and vestibular dysfunction.
Be a part of medical history.
Data from this study will help prove to the FDA what so many have known for over a decade: GyroStim is the most effective treatment for recovery from concussion/mTBI.
If you are going to travel, travel here.
We understand that not everyone has a GyroStim in their backyard --- yet. Many people travel to clinics outside of their home state. If this applies to you, consider traveling to NeuroScience Group, a state-of-the-art neurology practice located just outside of Green Bay, WI, where this historic study is taking place.
If you have a concussion/mTBI and are considering traveling to a clinic for GyroStim treatment, please consider traveling to NeuroScience Group where your de-identified treatment data can contribute to the advancement of medical science and the improvement of the standard of care for concussion recovery.
Why this study matters.
Although this is an unpaid clinical study, your data will move forward UltraThera Technology's mission to make GyroStim available and covered by insurance to millions more people like you who are seeking recovery from persistent post-concussion/mTBI symptoms.
For details about the study and
recruitment information contact
Nikki Seibert, Study Coordinator @
###